These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 25565816)
21. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades. Crevar CJ; Carter DM; Lee KY; Ross TM Hum Vaccin Immunother; 2015; 11(3):572-83. PubMed ID: 25671661 [TBL] [Abstract][Full Text] [Related]
22. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine. Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus). Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940 [TBL] [Abstract][Full Text] [Related]
24. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. Du L; Zhao G; Sun S; Zhang X; Zhou X; Guo Y; Li Y; Zhou Y; Jiang S PLoS One; 2013; 8(1):e53568. PubMed ID: 23320093 [TBL] [Abstract][Full Text] [Related]
25. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens. Bertran K; Thomas C; Guo X; Bublot M; Pritchard N; Regan JT; Cox KM; Gasdaska JR; Dickey LF; Kapczynski DR; Swayne DE Vaccine; 2015 Jul; 33(30):3456-62. PubMed ID: 26067184 [TBL] [Abstract][Full Text] [Related]
26. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus. Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174 [TBL] [Abstract][Full Text] [Related]
27. A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity. Matsuda K; Migueles SA; Huang J; Bolkhovitinov L; Stuccio S; Griesman T; Pullano AA; Kang BH; Ishida E; Zimmerman M; Kashyap N; Martins KM; Stadlbauer D; Pederson J; Patamawenu A; Wright N; Shofner T; Evans S; Liang CJ; Candia J; Biancotto A; Fantoni G; Poole A; Smith J; Alexander J; Gurwith M; Krammer F; Connors M J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33529172 [TBL] [Abstract][Full Text] [Related]
28. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
29. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947 [TBL] [Abstract][Full Text] [Related]
30. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus. Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171 [TBL] [Abstract][Full Text] [Related]